The abstract is read at the publisher; the summary is JClub's.
Antenatal inflammatory chemokine signatures in hypertensive disorders of pregnancy predict adverse left ventricular structure and function 3–6 months postpartum despite systemic inflammation resolving.
- Why it matters: Maternal cardiac dysfunction is linked to hypertensive disorders of pregnancy, but it is unclear whether pregnancy inflammation leaves a persistent postpartum cardiac maladaptation.
- What they did: In a prospective longitudinal study, cardiac function and circulating inflammatory profiles were measured during pregnancy and 3–6 months postpartum, and a mechanistic mouse model was used to test progesterone’s role.
- The result: In the mouse model, reduced antenatal progesterone drives inflammation and postpartum cardiac dysfunction, and antenatal (embryonic day 14.5) progesterone treatment prevents postpartum dysfunction (postpartum day 28).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.